142
Views
1
CrossRef citations to date
0
Altmetric
Review

High sensitivity troponins in contemporary cardiology practice: are we turning a corner?

, , &
Pages 49-57 | Received 08 Sep 2017, Accepted 15 Dec 2017, Published online: 28 Dec 2017

References

  • Babuin L, Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury. Cmaj. 2005;173(10):1191–1202.
  • Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581–1598.
  • Saenger AK, Jaffe AS. Requiem for a heavyweight: the demise of creatine kinase-MB. Circulation. 2008;118(21):2200–2206.
  • Apple FS, Collinson PO, Biomarkers IFCC TF-CB. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem. 2012;58(1):54–61.
  • Takeda S, Yamashita A, Maeda K, et al. Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature. 2003;424(6944):35–41.
  • Ricchiuti V, Voss EM, Ney A, et al. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem. 1998;44(9):1919–1924.
  • Apple FS. Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB. Clin Chim Acta. 1999;284(2):151–159.
  • Mehta SR, Granger CB, Boden WE, et al. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009;360(21):2165–2175.
  • Hoenig MR, Doust JA, Aroney CN, et al. Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era. Cochrane Database Syst Rev. 2006;CD004815. doi:10.1002/14651858.CD004815.pub2(3)
  • Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327(3):146–150.
  • Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335(18):1342–1349.
  • Morrow DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. Jama. 2001;286(19):2405–2412.
  • Tate JR. Troponin revisited 2008: assay performance. Clin Chem Lab Med. 2008;46(11):1489–1500.
  • Lippi G, Targher G, Franchini M, et al. Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications. Clin Chem Lab Med. 2009;47(10):1183–1194.
  • Panteghini M. Selection of antibodies and epitopes for cardiac troponin immunoassays: should we revise our evidence-based beliefs? Clin Chem. 2005;51(5):803–804.
  • Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361(9):868–877.
  • Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. Jama. 2011;306(24):2684–2693.
  • Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361(9):858–867.
  • Mueller M, Biener M, Vafaie M, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem. 2012;58(1):209–218.
  • Christ M, Bertsch T, Popp S, et al. High-sensitivity troponin assays in the evaluation of patients with acute chest pain in the emergency department. Clin Chem Lab Med. 2011;49(12):1955–1963.
  • Apple FS. A new season for cardiac troponin assays: it’s time to keep a scorecard. Clin Chem. 2009;55(7):1303–1306.
  • Daniels LB. The enemy of good?: making the most of highly sensitive troponin assays. J Am Coll Cardiol. 2013;61(18):1914–1916.
  • Apple FS, Jaffe AS, Collinson P, et al. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem. 2015;48(4–5):201–203.
  • Apple FS, Sandoval Y, Jaffe AS, et al. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clin Chem. 2017;63(1):73–81.
  • Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315.
  • Twerenbold R, Jaeger C, Rubini Gimenez M, et al. Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction. Eur Heart J. 2016;37(44):3324–3332.
  • Pickering JW, Than MP, Cullen L, et al. Rapid Rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin t measurement below the limit of detection: a collaborative meta-analysis. Ann Intern Med. 2017;166(10):715–724.
  • Kavsak PA, Clark L, Jaffe AS. Effect of Repeat Measurements of High-Sensitivity Cardiac Troponin on the Same Sample Using the European Society of Cardiology 0-Hour/1-Hour or 2-hour algorithms for early rule-out and rule-in for myocardial infarction. Clin Chem. 2017;63(6):1163–1165.
  • Pickering JW, Greenslade JH, Cullen L, et al. Assessment of the European Society of Cardiology 0-Hour/1-hour algorithm to rule-out and rule-in acute myocardial infarction. Circulation. 2016;134(20):1532–1541.
  • Than M, Herbert M, Flaws D, et al. What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department?: a clinical survey. Int J Cardiol. 2013;166(3):752–754.
  • Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634–2653.
  • Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33(20):2551–2567.
  • Wildi K, Gimenez MR, Twerenbold R, et al. Misdiagnosis of myocardial infarction related to limitations of the current regulatory approach to define clinical decision values for cardiac troponin. Circulation. 2015;131(23):2032–2040.
  • Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012;58(11):1574–1581.
  • Aw TC, Phua SK, Tan SP. Measurement of cardiac troponin I in serum with a new high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender. Clin Chim Acta. 2013;422:26–28.
  • Cullen L, Greenslade JH, Carlton EW, et al. Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest pain. Heart. 2016;102(2):120–126.
  • Shah AS, Griffiths M, Lee KK, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. Bmj. 2015;350:g7873.
  • Rubini Gimenez M, Reiter M, Twerenbold R, et al. Sex-specific chest pain characteristics in the early diagnosis of acute myocardial infarction. JAMA Intern Med. 2014;174(2):241–249.
  • Koerbin G, Abhayaratna WP, Potter JM, et al. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin Biochem. 2013;46(16–17):1636–1643.
  • Saenger AK, Beyrau R, Braun S, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta. 2011;412(9–10):748–754.
  • Eggers KM, Lind L, Venge P, et al. Factors influencing the 99th percentile of cardiac troponin I evaluated in community-dwelling individuals at 70 and 75 years of age. Clin Chem. 2013;59(7):1068–1073.
  • Collinson PO, Heung YM, Gaze D, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem. 2012;58(1):219–225.
  • Hammarsten O, Fu ML, Sigurjonsdottir R, et al. Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. Clin Chem. 2012;58(3):628–637.
  • Egstrup M, Schou M, Tuxen CD, et al. Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure. Am J Cardiol. 2012;110(4):552–557.
  • Mckie PM, Abouezzeddine OF, Scott CG, et al. High-sensitivity troponin I and amino-terminal pro–B-type natriuretic peptide predict heart failure and mortality in the general population. Clin Chem. 2014;60(9):1225–1233.
  • Nakamura Y, Yoshihisa A, Takiguchi M, et al. High-sensitivity cardiac troponin T predicts non-cardiac mortality in heart failure. Circ J. 2014;78(4):890–895.
  • Ferreira JP, Santos M, Almeida S, et al. High-sensitivity troponin T: a biomarker for diuretic response in decompensated heart failure patients. Cardiol Res Pract. 2014;269604:2014.
  • Diez M, Talavera ML, Conde DG, et al. High-sensitivity troponin is associated with high risk clinical profile and outcome in acute heart failure. Cardiol J. 2016;23(1):78–83.
  • Miao DM, Zhang LP, Yu HP, et al. Serum levels of high-sensitivity troponin T: a novel marker for left ventricular remodeling and performance in hypertensive subjects. Genet Mol Res. 2014;13(3):5143–5153.
  • Seliger SL, Hong SN, Christenson RH, et al. High-Sensitive cardiac troponin t as an early biochemical signature for clinical and subclinical heart failure: MESA (Multi-Ethnic Study of Atherosclerosis). Circulation. 2017;135(16):1494–1505.
  • Kumar N, Michelis MF, Devita MV, et al. Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay. Nephrol Dial Transplant. 2011;26(2):665–670.
  • Pianta TJ, Horvath AR, Ellis VM, et al. Cardiac high-sensitivity troponin T measurement: a layer of complexity in managing haemodialysis patients. Nephrology (Carlton). 2012;17(7):636–641.
  • Van Der Linden N, Cornelis T, Kimenai DM, et al. Origin of cardiac troponin T elevations in chronic kidney disease. Circulation. 2017;136(11):1073–1075.
  • Segre CA, Hueb W, Garcia RM, et al. Troponin in diabetic patients with and without chronic coronary artery disease. BMC Cardiovasc Disord. 2015;15:72.
  • Ostermann M, Lo J, Toolan M, et al. A prospective study of the impact of serial troponin measurements on the diagnosis of myocardial infarction and hospital and six-month mortality in patients admitted to ICU with non-cardiac diagnoses. Crit Care. 2014;18(2):R62.
  • Baron JM, Lewandrowski EL, Januzzi JL, et al. Measurement of high-sensitivity troponin T in noncardiac medical intensive care unit patients. Correlation to mortality and length of stay. Am J Clin Pathol. 2014;141(4):488–493.
  • Røsjø H, Varpula M, Hagve TA, et al. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med. 2011;37(1):77–85.
  • Avouac J, Meune C, Chenevier-Gobeaux C, et al. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors. J Rheumatol. 2014;41(2):248–255.
  • Walter T, Apfaltrer P, Weilbacher F, et al. Predictive value of high-sensitivity troponin I and D-dimer assays for adverse outcome in patients with acute pulmonary embolism. Exp Ther Med. 2013;5(2):586–590.
  • Høiseth AD, Neukamm A, Hagve TA, et al. The clinical value of serial measurement of high-sensitivity cardiac troponin T in acute exacerbations ofchronic obstructive pulmonary disease. Open Heart. 2014;1(1):e000001.
  • Faiz KW, Thommessen B, Einvik G, et al. Determinants of high sensitivity cardiac troponin T elevation in acute ischemic stroke. BMC Neurol. 2014;14:96.
  • Skytta T, Tuohinen S, Boman E, et al. Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy. Radiat Oncol. 2015;10:141.
  • Petrie CJ, Weir RA, Anwar MS, et al. High sensitivity troponin T in acute medicine; more questions than answers? Qjm. 2014;107(3):193–200.
  • Saad YM, Mcewan J, Shugman IM, et al. Use of a high-sensitivity troponin T assay in the assessment and disposition of patients attending a tertiary Australian emergency department: A cross-sectional pilot study. Emerg Med Australas. 2015;27(5):405–411.
  • Stein GY, Alon D, Korenfeld R, et al. Clinical implications of high-sensitivity cardiac troponin measurements in hospitalized medical patients. PLoS One. 2015;10(1):e0117162.
  • Shah AS, Anand A, Sandoval Y, et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet. 2015;386(10012):2481–2488.
  • Baron T, Hambraeus K, Sundström J, et al. Type 2 myocardial infarction in clinical practice. Heart. 2015;101(2):101–106.
  • Melberg T, Burman R, Dickstein K. The impact of the 2007 ESC-ACC-AHA-WHF Universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study. Int J Cardiol. 2010;139(3):228–233.
  • Javed U, Aftab W, Ambrose JA, et al. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. Am J Cardiol. 2009;104(1):9–13.
  • Gonzalez MA, Eilen DJ, Marzouq RA, et al. The universal classification is an independent predictor of long-term outcomes in acute myocardial infarction. Cardiovasc Revasc Med. 2011;12(1):35–40.
  • Thygesen K, Mair J, Giannitsis E, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012;33(18):2252–2257.
  • Shah AS, Newby DE, Mills NL. High sensitivity cardiac troponin in patients with chest pain. Bmj. 2013;347:f4222.
  • Makam AN, Nguyen OK. Use of cardiac biomarker testing in the emergency department. JAMA Intern Med. 2015;175(1):67–75.
  • Melanson SE, Conrad MJ, Mosammaparast N, et al. Implementation of a highly sensitive cardiac troponin I assay: test volumes, positivity rates and interpretation of results. Clin Chim Acta. 2008;395(1–2):57–61.
  • Shah AS, Mcallister DA, Mills R, et al. Sensitive troponin assay and the classification of myocardial infarction. Am J Med. 2015;128(5):493–501.e493.
  • Chapman AR, Adamson PD, Mills NL. Assessment and classification of patients with myocardial injury and infarction in clinical practice. Heart. 2017;103(1):10–18.
  • Alpert JS, Thygesen KA, White HD, et al. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med. 2014;127(2):105–108.
  • Stein GY, Herscovici G, Korenfeld R, et al. Type-II myocardial infarction–patient characteristics, management and outcomes. PLoS One. 2014;9(1):e84285.
  • Saaby L, Poulsen TS, Hosbond S, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med. 2013;126(9):789–797.
  • Sarkisian L, Saaby L, Poulsen TS, et al. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am J Med. 2016;129(4):446.e445-446.e421.
  • Chapman AR, Shah ASV, Anand A, et al. 113 Long term outcomes of patients with type 2 myocardial infarction or myocardial injury. Heart. 2016;102(Suppl 6):A80–A80.
  • Saunders JT, Nambi V, De Lemos JA, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation. 2011;123(13):1367–1376.
  • Thorsteinsdottir I, Aspelund T, Gudmundsson E, et al. High-Sensitivity cardiac troponin i is a strong predictor of cardiovascular events and mortality in the AGES-Reykjavik community-based cohort of older individuals. Clin Chem. 2016;62(4):623–630.
  • Iribarren C, Chandra M, Rana JS, et al. High-sensitivity cardiac troponin I and incident coronary heart disease among asymptomatic older adults. Heart. 2016;102(15):1177–1182.
  • Melki D, Lugnegård J, Alfredsson J, et al. Implications of introducing high-sensitivity cardiac troponin T into clinical practice: data from the SWEDEHEART registry. J Am Coll Cardiol. 2015;65(16):1655–1664.
  • Ford I, Shah AS, Zhang R, et al. High-Sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease. J Am Coll Cardiol. 2016;68(25):2719–2728.
  • Whelton SP, Mcevoy JW, Lazo M, et al. High-Sensitivity Cardiac Troponin T (hs-cTnT) as a predictor of incident diabetes in the atherosclerosis risk in communities study. Diabetes Care. 2017;40(2):261–269.
  • Cavender MA, White WB, Jarolim P, et al. Serial measurement of high sensitivity troponin i and cardiovascular outcomes in patients with type 2 diabetes mellitus in the EXAMINE Trial. Circulation. 2017. DOI:10.1161/CIRCULATIONAHA.116.024632
  • Wrigley P, Khoury J, Eckerle B, et al. Prevalence of positive troponin and echocardiogram findings and association with mortality in acute ischemic stroke. Stroke. 2017. DOI:10.1161/STROKEAHA.116.014561
  • Neukamm A, Einvik G, Didrik Høiseth A, et al. The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients. BMC Pulm Med. 2016;16(1):164.
  • Willeit P, Welsh P, Evans JDW, et al. High-Sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes in 154,052 participants. J Am Coll Cardiol. 2017;70(5):558–568.
  • Sandoval Y, Smith SW, Love SA, et al. Single high-sensitivity cardiac troponin i to rule out acute myocardial infarction. Am J Med. 2017;130(9):1076–1083 e1071.
  • Boeddinghaus J, Nestelberger T, Twerenbold R, et al. Direct comparison of 4 very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I. Circulation. 2017;135(17):1597–1611.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.